Raymond James & Associates’s Genesco GCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-15,668
Closed -$209K 3571
2020
Q1
$209K Sell
15,668
-1,823
-10% -$61.5K ﹤0.01% 3016
2019
Q4
$838K Buy
17,491
+3,693
+27% +$153K ﹤0.01% 2380
2019
Q3
$552K Sell
13,798
-200
-1% -$7.72K ﹤0.01% 2579
2019
Q2
$592K Sell
13,998
-3,584
-20% -$158K ﹤0.01% 2545
2019
Q1
$801K Sell
17,582
-6,049
-26% -$277K ﹤0.01% 2334
2018
Q4
$1.05M Sell
23,631
-3,572
-13% -$154K ﹤0.01% 2063
2018
Q3
$1.28M Sell
27,203
-2,277
-8% -$99.4K ﹤0.01% 2083
2018
Q2
$1.17M Buy
29,480
+5,126
+21% +$218K ﹤0.01% 2084
2018
Q1
$989K Buy
24,354
+1,727
+8% +$64.1K ﹤0.01% 2131
2017
Q4
$735K Buy
22,627
+661
+3% +$18.2K ﹤0.01% 2299
2017
Q3
$584K Sell
21,966
-86
-0.4% -$2.43K ﹤0.01% 2391
2017
Q2
$748K Buy
22,052
+2,627
+14% +$117K ﹤0.01% 2194
2017
Q1
$1.08M Buy
19,425
+909
+5% +$54.2K ﹤0.01% 1930
2016
Q4
$1.15M Buy
18,516
+18
+0.1% +$1.1K ﹤0.01% 1844
2016
Q3
$1.01M Buy
18,498
+3,636
+24% +$229K ﹤0.01% 1878
2016
Q2
$956K Sell
14,862
-1,134
-7% -$75K ﹤0.01% 1757
2016
Q1
$1.16M Buy
15,996
+1,685
+12% +$109K ﹤0.01% 1601
2015
Q4
$813K Buy
14,311
+1,534
+12% +$88.7K ﹤0.01% 1747
2015
Q3
$729K Sell
12,777
-87
-0.7% -$5.4K ﹤0.01% 1760
2015
Q2
$849K Sell
12,864
-18
-0.1% -$1.24K ﹤0.01% 1808
2015
Q1
$918K Buy
+12,882
New +$934K ﹤0.01% 1707

Other funds holding GCO

Raymond James & Associates's GCO Position: Q2 2020 in Review

Raymond James & Associates sold out of Genesco (GCO) in Q2 2020, closing a stake of 15,668 shares — an estimated $209K sold.

Raymond James & Associates first reported a position in GCO in Q1 2015 and held it in 21 quarters. The position peaked at $1.28M in Q3 2018. 138 funds tracked by Wall St. Rank hold GCO as of Q2 2020.

  • Raymond James & Associates reported no remaining Genesco position as of Q2 2020 after selling out during the quarter.
  • Raymond James & Associates sold 15,668 Genesco shares in Q2 2020, an estimated $209K.
  • Raymond James & Associates first reported a position in Genesco in Q1 2015 and held it in 21 quarters.
  • Raymond James & Associates's Genesco position peaked at $1.28M in Q3 2018.
  • 138 funds tracked by Wall St. Rank held Genesco as of Q2 2020.

Based on Raymond James & Associates's 13F filing for Q2 2020, filed 28 Jul 2020.